Sort
23,748 grants matching “melanoma”
Illinois Oncology Research Association CCOP
$578,969John W Kugler · Oncology-Hematology Assoc-Central Ill · U10 · FY2007 · CA
Multifunctional Photosensitizers for Image-guided PDT of Brain Tumors
$578,886Ravindra K Pandey · Roswell Park Cancer Institute Corp · R01 · FY2009 · CA
Elucidation of Human Natural Killer Cell Development
$578,825Aharon G Freud · Ohio State University · R01 · FY2023 · CA
Multimeric Ligands for Targeting of Melanoma
$578,648Robert J Gillies · University Of Arizona · R01 · FY2006 · CA
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds
$578,620Gloria M. Petersen · Mayo Clinic Rochester · R01 · FY2016 · CA
Development of Aquatic Model Resources for Therapeutic Screens
$578,580John Harvey Postlethwait · University Of Oregon · R24 · FY2016 · OD
Technetium and Rhenium in Nuclear Medicine
$578,542Alun Gareth Jones · Harvard Medical School · R01 · FY2009 · CA
G alpha-q/11 Signaling and Inhibition in Ocular Melanoma
$578,437Kendall Jay Blumer · Washington University · R01 · FY2020 · CA
Diversification of Cytotoxic Effector Cells Via LPS-activated DCs
$578,305Anna Karolina Palucka · Baylor Research Institute · R01 · FY2010 · CA
Identifying the mechanism of anti-colorectal immunity induced by mucoinvasive colonic bacteria
$578,243Timothy Wesley Hand · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Immunotherapeutic responses to neoantigens in head and neck cancer
$578,036Ravindra Uppaluri · Dana-Farber Cancer Inst · R01 · FY2019 · DE
Immunotherapeutic responses to neoantigens in head and neck cancer
$578,036Ravindra Uppaluri · Dana-Farber Cancer Inst · R01 · FY2021 · DE
Immunotherapeutic responses to neoantigens in head and neck cancer
$578,036Ravindra Uppaluri · Dana-Farber Cancer Inst · R01 · FY2020 · DE
Elucidation of novel anti-angiogenic therapies for the prevention and treatment of neovascular glaucoma
$578,018Silvia V Montaner · University Of Maryland Baltimore · R01 · FY2023 · EY
Metabolic Targets in Pten-Tumors
$577,897Jeffrey A Smith · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2011 · CA
ROS EXPLOITATION TO INCREASE EFFICACY OF RAF PATHWAY INHIBITION IN MELANOMA
$577,739Cincinnati Univ Of · · FY2019 · Defense Health Agency
Discovery of Small Molecule Ligands for PHD1 Reader Domain of Histone Demethylase KDM5A
$577,690Danica Galonic Fujimori · University Of California, San Francisco · R01 · FY2021 · CA
Multidisciplinary Collaborative Clinical Research, Core Facilities and Other Clinical Services in NIDDK Program Area Diseases
$577,591James Balow · National Institute Of Diabetes And Digestive And Kidney Diseases · ZID · FY2015 · DK
Characterizing and predicting colitis in immune checkpoint blockade-treated cancer patients
$577,498Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai · U01 · FY2023 · DK
Characterizing and predicting colitis in immune checkpoint blockade-treated cancer patients
$577,498Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai · U01 · FY2021 · DK
Characterizing and predicting colitis in immune checkpoint blockade-treated cancer patients
$577,498Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai · U01 · FY2022 · DK
Multivalent Small Circular mRNA Vaccines for Melanoma Combination Immunotherapy
$577,293Guizhi Zhu · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Computational analysis of tumor ecosystems and their regulation and association with outcomes
$577,261Andrew J. Gentles · Stanford University · R01 · FY2024 · CA
Discovery of Glutaryl-CoA Dehydrogenase inhibitors for melanoma and pancreatic cancer
$577,198Eduard A. Sergienko · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · CA
A personalized approach to skin cancer prevention among adolescents
$577,157Yelena Ping Wu · University Of Utah · R01 · FY2020 · CA